Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
>
Shareholders and investors
> News
News
Find out more about ...
The Share
Investor's Calendar
News
Financial and Business Information
Public Statements Sent to CNMV
ESG
Corporate Governance
News searcher
Year
Year
-Year
2024
2023
2022
2021
2020
2019
2018
Sort by
Fecha publicación
Order
Asc
Desc
ROVI announces positive results from a Risperidone-ISM new trial
0 min
16 Dec, 2014
Nine-month period ended 30 September 2014 results press release
0 min
06 Nov, 2014
Nine-month period ended 30 September 2014 results presentation
0 min
06 Nov, 2014
First half 2014 results press release
0 min
30 Jul, 2014
First half 2014 results presentation
0 min
30 Jul, 2014
2014 first quarter results press release
0 min
29 Apr, 2014
2014 first quarter results presentation
0 min
29 Apr, 2014
Full year 2013 results press release
0 min
27 Feb, 2014
Full year 2013 results presentation
0 min
27 Feb, 2014
See more
